- Home
- QNCX vs NMS Comparison
QNCX vs NMS Comparison
Compare QNCX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- NMS
- Stock Information
- Founded
- QNCX 2012
- NMS 1993
- Country
- QNCX United States
- NMS United States
- Employees
- QNCX N/A
- NMS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- NMS Finance Companies
- Sector
- QNCX Health Care
- NMS Finance
- Exchange
- QNCX Nasdaq
- NMS Nasdaq
- Market Cap
- QNCX 85.9M
- NMS 71.2M
- IPO Year
- QNCX 2019
- NMS N/A
- Fundamental
- Price
- QNCX $1.65
- NMS $11.89
- Analyst Decision
- QNCX Strong Buy
- NMS
- Analyst Count
- QNCX 6
- NMS 0
- Target Price
- QNCX $8.00
- NMS N/A
- AVG Volume (30 Days)
- QNCX 263.4K
- NMS 12.0K
- Earning Date
- QNCX 11-12-2025
- NMS 01-01-0001
- Dividend Yield
- QNCX N/A
- NMS 4.11%
- EPS Growth
- QNCX N/A
- NMS N/A
- EPS
- QNCX N/A
- NMS N/A
- Revenue
- QNCX N/A
- NMS N/A
- Revenue This Year
- QNCX N/A
- NMS N/A
- Revenue Next Year
- QNCX N/A
- NMS N/A
- P/E Ratio
- QNCX N/A
- NMS N/A
- Revenue Growth
- QNCX N/A
- NMS N/A
- 52 Week Low
- QNCX $0.69
- NMS $9.21
- 52 Week High
- QNCX $2.45
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- QNCX 56.09
- NMS 63.79
- Support Level
- QNCX $1.59
- NMS $11.81
- Resistance Level
- QNCX $1.68
- NMS $12.19
- Average True Range (ATR)
- QNCX 0.06
- NMS 0.12
- MACD
- QNCX 0.01
- NMS -0.01
- Stochastic Oscillator
- QNCX 69.57
- NMS 41.18
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.